Zobrazeno 1 - 10
of 245
pro vyhledávání: '"Babjuk M"'
Autor:
Babjuk M; Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: marek.babjuk@fnmotol.cz.
Publikováno v:
European urology [Eur Urol] 2024 Aug; Vol. 86 (2), pp. 112-113. Date of Electronic Publication: 2024 May 25.
Autor:
Brisuda A; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic. antonin.brisuda@fnmotol.cz., Horňák J; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Žemličková B; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Háček J; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Babjuk M; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic.
Publikováno v:
International urology and nephrology [Int Urol Nephrol] 2024 Jul; Vol. 56 (7), pp. 2243-2250. Date of Electronic Publication: 2024 Feb 08.
Autor:
Mertens LS; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: l.mertens@nki.nl., Bruins HM; Department of Urology, Zuyderland Medical Center, Sittard-Heerlen, The Netherlands., Contieri R; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Babjuk M; Department of Urology, Teaching Hospital Motol, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Puig AC; Department of Urology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Escrig JLD; Department of Urology, Instituto Valenciano de Oncologia, Valencia, Spain., Gontero P; Division of Urology, Department of Surgical Sciences, AOU Citta della Salute e della Scienca, Torina School of Medicine, Turin, Italy., van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Liedberg F; Department of Urology, Skane University Hospital, Malmö, Sweden; Institute of Translational Medicine, Lund University, Malmö, Sweden., Martini A; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Masson-Lecomte A; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Mostafid H; Department of Urology, Royal Surrey Hospital, Guildford, UK., Neuzillet Y; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Pradere B; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Redlef J; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands., van Rhijn BWG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany., Rouanne M; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Rouprêt M; GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpetriere Hospital, Paris, France., Sæbjørnsen S; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands., Seisen T; GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpetriere Hospital, Paris, France., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, University of Jordan, Amman, Jordan; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Soria F; Division of Urology, Department of Surgical Sciences, AOU Citta della Salute e della Scienca, Torina School of Medicine, Turin, Italy., Soukup V; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic., Thalmann G; Department of Urology, Inselspital, University Hospital Bern, Bern, Switzerland., Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université Paris Cité, Paris, France., Mariappan P; Edinburgh Bladder Cancer Surgery, University of Edinburgh, Western General Hospital, Edinburgh, UK., Alfred Witjes J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun 20. Date of Electronic Publication: 2024 Jun 20.
Autor:
Kardoust Parizi M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Rouprêt M; Department of Urology, Pitié Salpêtrière Hospital, AP-HP, GRC 5, Predictive Onco-Urology, Sorbonne University, Paris, France., Singla N; Departement of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD., Teoh JY; Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China., Chlosta P; Department of Urology, Jagiellonian University, Cracow, Poland., Babjuk M; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Abufaraj M; Department of Special Surgery, Division of Urology, The University of Jordan, Amman, Jordan., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Klemm J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Matsukawa A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Jikei University School of Medicine, Tokyo, Japan., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fazekas T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Semmelweis University, Budapest, Hungary., Karakiewicz PI; Departement of Urology, Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada., Bhanvadia R; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Gontero P; Department of Surgical Sciences, Division of Urology, Torino School of Medicine, Turin, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Special Surgery, Division of Urology, The University of Jordan, Amman, Jordan; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Departments of Urology, Weill Cornell Medical College, New York, NY; Departement of Urology, Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Research Center for Evidence Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: sfshariat@gmail.com.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun 04; Vol. 22 (6), pp. 102133. Date of Electronic Publication: 2024 Jun 04.
Autor:
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Gontero P; Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy., Babjuk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Moschini M; Department of Urology, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy., Teoh JY; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China., Rouprêt M; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France., Trinh QD; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Chlosta P; Department of Urology, Jagiellonian University, Cracow, Poland., Nyirády P; Department of Urology, Semmelweis University, Budapest, Hungary., Abufaraj M; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan., Soria F; Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy., Klemm J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bekku K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan., Matsukawa A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Jikei University School of Medicine, Tokyo, Japan., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, Semmelweis University, Budapest, Hungary.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan.; Research Center for Evidence Medicine, Urology Department Tabriz University of Medical Sciences, Tabriz, Iran.
Publikováno v:
BJU international [BJU Int] 2024 Apr 16. Date of Electronic Publication: 2024 Apr 16.
Autor:
Babjuk M; Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czechia; Department of Urology, Medical University of Vienna, Vienna, Austria. Electronic address: marek.babjuk@fnmotol.cz.
Publikováno v:
European urology [Eur Urol] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Autor:
Ahmadi S; Division of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Ambite I; Division of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Brisuda A; Department of Urology, Motol University Hospital, 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Háček J; Department of Pathology and Molecular Medicine, Motol University Hospital, 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Haq F; Division of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Sabari S; Division of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Vanarsa K; Department of Biomedical Engineering, University of Houston, Houston, Texas, USA., Mohan C; Department of Biomedical Engineering, University of Houston, Houston, Texas, USA., Babjuk M; Department of Urology, Motol University Hospital, 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Svanborg C; Division of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e7091.
Autor:
Borcinova M; Gynecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic., Bartolini R; Lausanne Center for Immuno-oncology Toxicities (LCIT), Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Foley LK; Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TT, UK., Novak V; Department of Urology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Taborska P; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Stakheev D; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Rataj M; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Smrz D; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Fialova M; Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Hacek J; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Komarc M; Department of Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic., Vesely S; Department of Urology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Babjuk M; Department of Urology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Striz I; Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Bartunkova J; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Ozaniak Strizova Z; Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. Electronic address: zuzana.strizova@fnmotol.cz.
Publikováno v:
Translational oncology [Transl Oncol] 2024 Apr; Vol. 42, pp. 101891. Date of Electronic Publication: 2024 Feb 03.
Autor:
Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Rodríguez O; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Pisano F; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Soria F; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Čapoun O; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bauerová L; Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Pešl M; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bruins HM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Urology, Zuyderland Medical Center, Sittard/Heerlen, The Netherlands., Runneboom W; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Calatrava A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Rubio-Briones J; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Seles M; Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Cotte J; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France., Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Liedberg F; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Cohen D; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Lunelli L; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., El Sheikh S; Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Volanis D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Côté JF; Pathology, Pierre et Marie Curie Medical School, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France., Haitel A; Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Hacek J; Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Zlotta AR; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Pathology, University of Regensburg, Regensburg, Germany., Hulsbergen-van de Kaa CA; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LALM; Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Molinaro L; Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Llorente C; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.v.rhijn@nki.nl.; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. b.v.rhijn@nki.nl.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. b.v.rhijn@nki.nl.; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. b.v.rhijn@nki.nl.
Publikováno v:
International urology and nephrology [Int Urol Nephrol] 2024 Apr; Vol. 56 (4), pp. 1323-1333. Date of Electronic Publication: 2023 Nov 19.
Autor:
Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX., Apolo AB; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD., Babjuk M; Department of Urology, Teaching Hospital Motol, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Bivalacqua TJ; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Black PC; Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, PA., Buckley R; Department of Urology, North York General Hospital, Toronto, Ontario, Canada., Campbell MT; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Compérat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Grivas P; Department of Medicine, Division of Oncology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Gupta S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Kurtz NJ; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY., Lamm D; Patient Advocate, Bladder Cancer Advocacy Network (BCAN), Bethesda, MD., Lerner SP; BCG Oncology, Phoenix, AZ., Li R; Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX., McConkey DJ; Department of Genitourinary Oncology, H Lee Moffitt Cancer Center, Tampa, FL., Palou Redorta J; Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD., Powles T; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Psutka SP; Queen Mary University of London, London, United Kingdom., Shore N; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Steinberg GD; Carolina Urologic Research Center, Myrtle Beach, SC., Sylvester R; Department of Urology, Rush University Medical Center, Chicago, IL., Witjes JA; EAU NMIBC Guidelines Panel, Arnhem, the Netherlands., Galsky MD; Radboud University Medical Center, Nijmegen, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 10; Vol. 41 (35), pp. 5437-5447. Date of Electronic Publication: 2023 Oct 04.